The ankle-brachial index (ABI) is a simple, noninvasive test used to detect peripheral arterial disease (PAD) in the legs. It is the ratio of the ankle systolic blood pressure to the brachial systolic blood pressure. An ABI below 0.9 suggests significant narrowing of leg blood vessels. The ABI test involves measuring blood pressure in the ankle and arm with a blood pressure cuff and Doppler ultrasound. It provides information on the severity and extent of PAD.
Detailed history and its evaluation , examination of spine in general and local with special tests in cervical , thoracic outlet syndrome , lumbar spine and SI joint with diagrams, neurological examination both sensory and motor.
Detailed history and its evaluation , examination of spine in general and local with special tests in cervical , thoracic outlet syndrome , lumbar spine and SI joint with diagrams, neurological examination both sensory and motor.
CARDIAC TAMPONADE ( Cardiac emergency) • Cardiac Tamponade is a life threatening complication caused by excessive accumulation of fluid in the pericardium. Or • Compression of all cardiac chambers due to excessive accumulation of pericardial fluid leading to compromised cardiac out put.
Exercise testing is a non invasive procedure that provides diagnostic and prognostic information and evaluates an individual’s capacity for dynamic exercises
ROLE OF ANKLE BRACHIAL INDEX TO PREDICT PERIPHERAL ARTERIAL DISEASE, A STUDY ...Shantonu Kumar Ghosh
The presence of peripheral arterial disease (PAD) is associated with higher cardiovascular morbidity and mortality, regardless of gender or its clinical form of presentation (symptomatic or asymptomatic). PAD is considered an independent predictor for cardiovascular mortality, more important for survival than clinical history of coronary artery disease.¹
The ankle brachial index (ABI) is a sensitive and cost-effective screening tool for PAD. ABI is valuable for screening of peripheral artery disease in patients at risk and for diagnosing the disease in patients who present with lower-extremity symptoms. Normal cut-off values for ABI are between 0.9 and 1.4. An abnormal ankle-brachial index- below 0.9 - is a powerful independent marker of cardiovascular risk.²
Exercise tolerance testing (also known as exercise testing or exercise stress testing) is used routinely in evaluating patients who present with chest pain, in patients who have chest pain on exertion, and in patients with known ischaemic heart disease.
Management of peripheral vascular disease by Sunil Kumar Dahasunil kumar daha
Please find the power point on Management of peripheral vascular disease . I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
ECG In Ischemic Heart Disease - Dr Vivek Baliga ReviewDr Vivek Baliga
Dr Vivek Baliga Presentation on the role of ECG in the diagnosis of ischemic heart disease. Here, he covers the very basics in ECG diagnosis of heart disease. Suitable for medical students and physicians alike. For more health articles for patients, visit http://baligadiagnostics.com/category/dr-vivek-baliga/
CARDIAC TAMPONADE ( Cardiac emergency) • Cardiac Tamponade is a life threatening complication caused by excessive accumulation of fluid in the pericardium. Or • Compression of all cardiac chambers due to excessive accumulation of pericardial fluid leading to compromised cardiac out put.
Exercise testing is a non invasive procedure that provides diagnostic and prognostic information and evaluates an individual’s capacity for dynamic exercises
ROLE OF ANKLE BRACHIAL INDEX TO PREDICT PERIPHERAL ARTERIAL DISEASE, A STUDY ...Shantonu Kumar Ghosh
The presence of peripheral arterial disease (PAD) is associated with higher cardiovascular morbidity and mortality, regardless of gender or its clinical form of presentation (symptomatic or asymptomatic). PAD is considered an independent predictor for cardiovascular mortality, more important for survival than clinical history of coronary artery disease.¹
The ankle brachial index (ABI) is a sensitive and cost-effective screening tool for PAD. ABI is valuable for screening of peripheral artery disease in patients at risk and for diagnosing the disease in patients who present with lower-extremity symptoms. Normal cut-off values for ABI are between 0.9 and 1.4. An abnormal ankle-brachial index- below 0.9 - is a powerful independent marker of cardiovascular risk.²
Exercise tolerance testing (also known as exercise testing or exercise stress testing) is used routinely in evaluating patients who present with chest pain, in patients who have chest pain on exertion, and in patients with known ischaemic heart disease.
Management of peripheral vascular disease by Sunil Kumar Dahasunil kumar daha
Please find the power point on Management of peripheral vascular disease . I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
ECG In Ischemic Heart Disease - Dr Vivek Baliga ReviewDr Vivek Baliga
Dr Vivek Baliga Presentation on the role of ECG in the diagnosis of ischemic heart disease. Here, he covers the very basics in ECG diagnosis of heart disease. Suitable for medical students and physicians alike. For more health articles for patients, visit http://baligadiagnostics.com/category/dr-vivek-baliga/
Walif Chbeir: Medical Imaging of PneumoThorax (PNO)–2Walif Chbeir
Dr. Walif Chbeir outlines in detail the medical imaging practice and diagnostic approach of pneumothorax (also known as PNO). This is the second in a four-part piece on PNO by Chbeir.
Walif Chbeir: Medical Imaging of PneumoThorax (PNO)–1Walif Chbeir
Dr. Walif Chbeir outlines in detail the medical imaging practice and diagnostic approach of pneumothorax (also known as PNO). This is the first in a four-part piece on PNO by Chbeir.
Walif Chbeir: Medical Imaging of PneumoThorax (PNO)–3Walif Chbeir
Dr. Walif Chbeir outlines in detail the medical imaging practice and diagnostic approach of pneumothorax (also known as PNO). This is the third in a four-part piece on PNO by Chbeir.
Doppler of Lower Limb Arteries. Technical Aspects.Walif Chbeir
Technique of Doppler of LLA Description: General Rules, Role and place of Real-Time Gray-Scale Imaging, Duplex Doppler Sonography, Color Doppler sonography and of Power Doppler sonography. Scanning Technique is described as well as Interpretation and Reporting.
PAD can be diagnosed in asymptomatic individuals by a combination of physical examination and simple, noninvasive Doppler ultrasonography to measure the ankle–brachial index
Appropriate level of monitoring is important in anaesthesia. Monitors should be sensitive enough to be able to detect early changes in hemodynamics. There have been major advance in non invasive monitoring in the recent past to make them more user friendly & also provide data which was till recently possible by invasive monitors only. Non invasive monitoring has limitations because of physical principle involved and other prerequisites required for accuracy. Thus non invasive monitors may not be sensitive enough to pick early changes in hemodynamic in sick patients. In this review we discuss the limitations of non invasive hemodynamic monitoring and factors that may influence their accurate working.
Diagnostic guidelines for peripheral arterial diseasePerimed
The aim of this document is to summarize the recommendations and diagnostic guidelines provided by different societies and associations for the assessment of peripheral arterial disease, critical limb ischemia, diabetic foot ulcers and chronic wounds.
Society of Radiologists in Ultrasound Consensus Conference: The consensus panel developed recommendations for diagnosis and stratification of ICA stenosis. These recommendations were derived from analysis of numerous studies and do not represent the results of any one laboratory or study. For a particular laboratory setting, internal validation is encouraged when possible. This may yield alternative diagnostic criteria that can be used successfully at that facility. However, each laboratory should have a single set of diagnostic criteria that is applied uniformly.
Medical imaging practice, diagnosis, symptoms and treatment for Cerebral Cavernous Malformation, written, edited and reviewed by Dr Walif Chbeir. Images can be found on WalifChbeir.net.
Normal Labral Variant Figures II - Walif ChbeirWalif Chbeir
The second portion of the figures from the Normal Labral Variants piece from Dr. Walif Chbeir. Other similar reports can be accessed via Walif Chbeir's slideshare account.
Walif Chbeir provides an in-depth look at labral variants and the analysis of CT and MRI scans on patients.
In this article, we discuss, describe and illustrate the normal anatomic variants of the glenoid labrum, the Biceps labral complex and of the gleno-humeral Ligaments as well as their differenciation of some labral tears with wich they could be easily confused. From this perspective, Resonance Magnetic Imaging Pitfalls are also described.
Medical Imaging of Pneumothorax (PNO)-Walif ChbeirWalif Chbeir
Walif Chbeir's scholarly work on the medical imaging of PneumoThorax or PNO. Explores what PNO is, images are taken and analyzed and takeaways.
Thorough review of PNO Radiology : Etiologies, Symptoms and Signs, Complications, PhysioPathology, Imaging ( XRay, CT Scan, UltraSonography) Mimics, degree of Collapse and indication of Drainage, Tension PNO, Underlying parenchymal lung disease, PNO In critical care and ARDS, Ultrasonography: Indication, technique and signs of PNO. Management of PNO.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Ankle-Brachial Index (ABI) --Walif Chbeir
1. Edited on June 25, 2016
Ankle-Brachial Index (ABI)
No financial relationships with commercial entities to disclose.
INTRODUCTION
The anklebrachial pressure index (ABPI) or anklebrachial index (ABI) is the ratio of the blood
pressure at the ankle to the higher of the brachial systolic blood pressures, which is the
best estimate of central systolic blood pressure.
It is a noninvasive, simple, valid, reliable and cot effective test wich is used to detect
lower extremity peripheral arterial disease (PAD), to measure the severity of
atherosclerosis in the legs but is also an independent predictor of mortality, as it
reflects the burden of atherosclerosis (5,16,17). However, alone it is not appropriate to
detect PAD (Peripheral Arterial Disease) because of possibility of false-negative
findings and does not give enough directions for revascularisation in term of
localization and characterization.
Lower extremity peripheral arterial disease (PAD) is a frequent, chronic, progressive
vascular disease and associated with significant morbidity and mortality (18).
Risk factors for PAD (2,12) are Advanced age (> 70yr). Smoking, past and present
diabetes, dyslipidemia, hypertension, hyperhomocysteinemia, chronic renal
insufficiency, family history of cardiovascular disease.
A lot of persons with APAD are undiagnosed because they are asymptomatic or
have atypical symptoms.
The ABI is also used as a prognostic marker for cardiovascular events, even in
the absence of symptoms of PAD.
2. INDICATIONS
1- Detection of PAD in all all patients who present with symptoms (pain that restrict
walking, ischemic pain at rest) and signs (reduced or absent pedal pulses on palpation,
skin that is cool, shiny, hairless or thin, thickening of the nails, abnormal capillary refill
time, pallor of distal extremities on elevation, leg pain and tissue ulceration or necrosis)
(12) suggestive of peripheral artery disease.
Measuring ABI to detect peripheral artery disease is a more sensitive and reliable test
compared to palpation of a pedal pulse, especially in patients who are obese or who
have significant oedema (12).
The ABI can provide also provide reliable information about the severity of the disease.
It can exclude other causes of calf pain : Spinal Stenosis, Venous, Raynaud
Phenomena and popliteal artery entrapment.
2- In the absence of revascularisation, ABI can be used as a Marker of PAD
Progression and clinical deterioration. It is not however correlate with clinical
amelioration (5).
3- Detection of PAD in asymptomatic patients
Patients with PAD are frequently asymptomatic. Most commonly, they have atypical leg
pain and a few present with typical claudication (12) .
There is currently insufficient evidence to recommend population screening for
peripheral artery disease using ABPI 3in 12. However, an ABI should be conducted on
patients presenting with risk factors to detect PAD, so that therapeutic interventions
known to diminish their increased risk of myocardial infarction (MI), stroke, and death
may be offered (2 in 2) .
Screening of PAD is recommended for patients presenting with risk factors (12):
- > 65-70 ans regardless of risk-factor status
- ⩾ 50 ans + 1 FRCV ( particularly for tabaccos and diabetes)
3. - ⩾ 40 ans + diabètes + 1 other Risk Factor.
- All people with a Framingham risk score (age, Total CT, cigarette smoking, HDL CT, Systolic
blood pressure) > 10%
- Other atherosclerosis location ( coronary a. , carotids, Renal a.…).
- Absence of Tibial posterior pulse.
4- ABI prior to surgery: Before leg or foot surgery (12) to exclude PAD that may result
in vascular complications and before wound debridement to determine adequate
arterial blood flow (1).
5- ABI prior to compression therapy for patients with venous disease or ulceration, to
exclude peripheral artery disease wich will induce complications.
- If the ABI is less than 0.8, le degré de compression devrait être réduit et la
compression contre indiquée si l’ABI is less than 0,5 (1).
6- ABPI can be used as a marker of cardiovascular risk both in the general
population free of clinical CVD and in patients with established CVD (5,12).
7- ABI is useful in the setting of lower extremity traumatism with suspiction of
arterial injury (10) :
An ABI less than 0.90, require CTA or Angiography or operative exploration in an
unstable patient.
An ABI greater than 0.90 decreases the likelihood of an arterial injury: F/U by serial ABI
vs Delayed Vascular Imaging.
Contre-Indications
1- Patients who are unable to remain supine for the duration of the examination.
2- Treadmill testing may be inappropriate for people who are obese, need assistance
to walk or limited by comorbidities such as Aortic aneurysm.
3- ABI measurement is also contraindicated in a patient in whom the use of an
occlusive sphygmomanometer cuff may worsen the extremity injury.
4. 4- Bilateral subclavian stenosis.
5- The use of the cuff over a distal bypass should be avoided (risk of bypass
thrombosis).
ABI PROCEDURE With the Doppler Method
Courtesy of Wikipedia, the free encyclopedia (Anklebrachial pressure index).
See also Images at : http://emedicine.medscape.com/article/1839449-overview#a3
* An ABI measurement can usually be performed in less than 10 minutes.
Standardisation of the technique used to measure the ABI was juged necessary because the
result may vary and hence the estimate prevalence of PAD (5).
* Before performing ABI, it is important to obtain a thorough history, symptoms and
clinical signs.
* Material:
Hand-held portable Doppler device with a frequency of 8 – 10 MHz; although 5 MHz
probes may be better for patients with significant ankle oedema.
Appropriately sized sphygmomanometer (blood pressure cuff) for the upper and lower
extremities. The cuff width should be, at a minimum, 40 % greater than the diameter of
the extremity (5).
And Ultrasonographic gel.
5. * Patient in supine position, with the arms and legs at the same level as the heart,
relaxed for a minimum of 10 minutes before measurement.
The patient should not smoke at least 2 hours before the ABI measurement.
Ideally, the ABI must be performed in a quiet, warm environment to prevent
vasconstriction of the arteries. If the room is cold, warm the patient with blankets.
The patient should stay still during the pressure measurement. If the patient is unable
to not move his/her limbs (eg, tremor), other methods should be considered.
The ABI procedure may cause discomfort for patients with lower leg pain or cellulitis. If
ulcers or wounds are present on the ankle then a protective barrier, e.g. a plastic wrap,
should
be placed over the affected area before the cuff is applied.
* The ankle cuff should go on the leg between the malleolus and the calf. Enough room
should be left below both cuffs (approximately five centimetres above the medial
malleolus and approximately two to three centimetres above the antecubital fossa for
the brachial pressure).
Make sure that cuff completely encircles lower extremity and wrapped without wrinkles
and placed securely to prevent slipping and movement during the test.
* Artery is palpated by hand before Doppler device is used. Place small amount of
ultrasound transmission gel at landmark where artery was located. Identify artery with
Doppler device. Upon application of Doppler probe, arterial pulsations should be
clearly audible before cuff is inflated. If they are not, reposition probe until appropriate
sound is obtained. Typically, Doppler probe must be positioned at 45- 60 degrees, not
at 90 degrees.
* The blood pressure cuff is inflated proximal to the artery in question. The inflation continues
20- 30mm above the pressure at wich the brachial pulse becomes inaudible by Doppler. The
blood pressure cuff is then slowly deflated (2–3 mm Hg per heartbeat). When the artery's
pulse is redetected through the Doppler probe, the pressure in the cuff at that moment indicates
the systolic pressure of that artery.
The maximum inflation is 300 mm Hg. If the flow is still detected, the cuff should be
deflated rapidly to avoid pain.
6. * The higher systolic reading of the left and right arm brachial artery is generally used
in the assessment.
* The pressures in each foot's posterior tibial artery and dorsalis pedis artery are
measured. Obtain the anterior tibial and posterior tibial systolic pressures of the
extremity in question, and select the higher of the 2 values as the ankle pressure
measurement. The posterior tibial pulse is best appreciated just dorsal and inferior to
the medial malleolus. The dorsalis pedis pulse is best appreciated on the dorsum of the
foot between the proximal section of the first and second metatarsals, usually above
the navicular bone.
The measurement of the systolic pressure of the dorsalis pedis arteries may not be
possible in all patients as 12% of the general population has a congenital absence of
the dorsalis pedis pulse
* Some (11) advocate to repeat each measure 2-3 times, especially for people who
have little experience with the handling of Doppler probes and measuring the ABI.
However, the Scientific Statement of the AHA (5) states to wait one minute at least
before reinflating the cuff because the accuracy of measurement of ABI depend on the
number of measurements.
* ABI for each leg is obtained by dividing the highest ankle systolic blood pressure
of dorsalis pedis or posterior tibial artery by the highest of the left and right arm
brachial systolic blood pressure.
The ABI must be calculated separately for each leg.
ABI =
Higher of either the dorsalis pedis or posterior tibial pressures
Higher of the brachial pressures
* Usually, the systolic pressure is first measured at the arm and ankle and
subsequently at ankles. However, the AHA recommends (5), for standardization
purpose, that the measurement sequence must be looped in clockwise or in
7. counterclockwise starting with an arm and ending by it ( e.g. Right Arm- Right Ankle-
Left Ankle- Left Arm- Right Arm) to reduce the effect of "white coat" on the first
measure. The average of the 2 measurements is to retain unless the difference
between the two (for the 1st arm) exceeds 10mmHg which case the 2nd measure is
only retained.
* For any situation, when the ABI is initially determined to be between 0.80 and 1.00, it
is reasonable to repeat the measurement. The measurements should be repeated
then in the reverse order of the first sequence starting with opposite arm (5).
* Postexercise ABI
This test is indicated for borderline ABI.
It usually lasts 5 to 15 minutes, sometimes less (15), depending on the importance of
any discomfort but for some (8), patient should not exercise for longer than 5 minutes.
Anyway, the patient must exercice only to the point of claudication.
Ankle pressures are then measured immediately after the exercise and at 3minute
intervals until the pressures return to preexercise levels (8).
The walk is usually undertaken with a small incline (10%). The speed is usually from
3km per H. and can vary from 2 to 5 km / h. This elevation and speed simulate the
circulatory response induced by normal ambulation (8). It is important that the same
speed and elevation are consistent for each patient on followup (8).
Treadmill testing may be inappropriate for people who need assistance to walk or who are
limited by other medical conditions.
In addition to evaluating the effect of exercise on the ankle level blood pressure,
treadmill exercise testing also offers a means to characterize the functional impact of
claudication symptoms. The distance walked before the onset of symptoms (painfree
walking distance) and the maximum distance that can be walked can be measured
using a standardized speed and grade on the treadmill. These values establish a
baseline for comparison, allowing objective assessment of change in walking
performance with medical therapy or interventions.
8. An alternative method simple method wich doesn’t need special equipment, the active
pedal plantar flexion technique, has been assessed for office purpose. It consists of
heel raising while standing. Excellent correlation of this method have been obtained in
correlation with treadmill test (5).
* Toe -Brachial Pressure Index (8, 13)
Compares the toe pressure to the arm pressure and is derived by dividing the toe
systolic pressure by the higher of the right and left arm’s systolic pressures.
Continuous wave Dopplers are not reliable to measure toe pressures due to the small
size of digital arteries and vasospasms if toes are cold.
Toe pressures, when indicated ( see below) are commonly measured in the vascular
laboratory by vascular technicians using standard laboratory photoplethysmography
(PPG) equipment. Toe pressures can be also measured by clinicians using a portable
PPG if the clinician is educated/skilled in the use of the equipment and it is available.
RESULTS INTERPRETATION.
*
ABI------------------------------------------------------- Perfusion Status
> 1.3 -----------------------------------------------Elevated, incompressible vessels
> 1.0 -----------------------------------------------------------Normal
0.99- 0.91 ------------------------------------------------------ Borderline values
< 0.9----------------------------------------------------- PAD= Lower extremity arterial disease
9. - An ABI <0.9 suggests significant narrowing of one or more blood vessels in the leg.
- The majority of patients with claudication have ABIs ranging from 0.3 to 0.9.
- IPS entre 0.7 et 0.9 : Low intensity well compensated arterial disease. Stenosis> 50%
at this stage. Cardiovascular risk would be the same in a limping and in an
asymptomatic patient with IPS <0.9 (6).
- IPS entre 0.5 et 0.7 : Moderately Compensated Arterial Disease (6).
- Rest pain or severe occlusive disease typically occurs with an ABI <0.5. This is a
critical ischemia. Patients have pretty high likelihood of developing ischemic leg pain,
to have ulcers that do not heal and large rate of death and amputation (6).
- ABIs <0.2 are associated with ischemic or gangrenous extremities.
- IPS > 1.3 : Médiacalcosis. The arteries are incompressible. It’s another
cardiovascular risk marker. Often in the setting of diabetes, advanced age and renal
failure. Referral to a vascular laboratory shoulds be regarded, as this result is
Clinically inconclusive.
* ABI in Case of Clinical Presentation of PAD
- The ABI test approaches 95% accuracy in detecting PAD. However, a normal ABI
value does not absolutely rule out the possibility of PAD. So, when the ABI is >0.90 but
there is clinical suspicion of PAD, postexercise ABI or other noninvasive tests, which
may include imaging, should be considered (5).
* Postexercise ABI
An ABI of 0.91-0.99 is considered borderline. The patient may be asymptomatic at rest
but may experience symptoms when ambulating. When there is an additional reasons
to suspect peripheral artery disease, e.g. symptoms and risk factors, further
investigations, such Treadmill testing wich rises the sensitivity of the ABI to detect PAD,
may be recommended (10).
In Healthy patients: There is Mild decrease in the ABI (average of 5%) when measured
immediately after exercise cessation. The ankle pressure then increases rapidly and reaches the
10. pre-exercise values within 1 to 2 minutes. A recovery of at least 90% of the ABI to baseline
value within the first 3 minutes after exercise was found to have a high specificity to rule out
PAD (5).
In the case of even moderate occlusive PAD (typically in the proximal vessels), the ankle
pressure decreases of more than 30 mm Hg during exercice or a postexercise, ABI
decreases of >20% and the recovery time to the pre-exercise value after exercise cessation is
prolonged, proportional to the severity of PAD (5). Critical ischemia and vascular
claudication cause a dramatic decrease in the postexercise ankle pressure to 60
mmHg or less (8).
When postexercise ankle pressures initially decrease but return to baseline values
within 3- 5 minutes, a single segment lesion is most often indicated (8).
Reconstitution of distal vessels is significantly delayed when multisegmental disease
is present. In such cases, ankle pressures return to baseline values within 10-12
minutes dependent on the extent of collateral compensatory flow (8).
* ABI as a Marker of PAD Progression.
In the absence of revascularization, an ABI decrease is correlated with clinical
deterioration. Clinical improvement in terms of an increased walking distance, however,
is not correlated with an ABI increase
Clinical prognosis of the limb is better predicted by ankle pressure rather than the ABI.
An ankle pressure < 50 mm Hg has been reported to be associated with higher risk
for amputation (19).
* ABI is a Marker of Cardiovascular Risk and Atherosclerosis
Un ABI <0.90 or >1.40 are considered at increased risk of cardiovascular events and mortality
independently of the presence of symptoms of PAD and other cardiovascular risk factors (5).
The ABS improves Framingham score's ability to predict CV complications for patients
classified at "low risk or intermediate" (11).
* After performing a vascular examination, criteria that would indicate an increased
urgency of referral to a vascular surgeon include:
- An ABPI < 0.5
11. - Known peripheral artery disease presenting with a new ulcer or area of necrotic
tissue
- An ulcer that is not responding to treatment
- Intermittent claudication when walking for less than 200 m
- Young and otherwise healthy patients with claudication to rule-out rare causes,
e.g. popliteal artery entrapment
* Discussion with a vascular surgeon should also be considered when:
There is doubt concerning the patient’s diagnosis
There is uncertainty around the significance of an ABPI result
There is doubt about the need for treatment or what treatment options are available
METHOD LIMITATIONS
* ABPI is known to be unreliable on patients with arterial calcification (hardening of the
arteries) which results in less or incompressible arteries, as the stiff arteries produce
falsely elevated ankle pressure, giving false negatives. This is often found in patients
with diabetes mellitus, renal failure, rheumatoid arthritis or heavy smokers. Vascular
Calcifications doesn’t mean that there is underlying stenotic or occlusion lesion but
stenosis is frequently present and can’t be excluded by normal ABI but ABI values
above 1.3 should be investigated further. This may be obvious (ABI above 1.3) but
when the arteries are partially calcified it can simulate normal ABI but actually the
values are decreased . So, Toe pressures/ brachial index are recommended if the
ABI is > 1.3 because the digital arteries are generally less affected by
calcifications than the ankle arteries and Comparison with pedal artery velocity
waveform shape is prudent.
* False negative can be induced by large collateral circulation supplying downstream
arterial stenosis or occlusion. ABI can be normal while patient experience claudication
with activity. Further vascular evaluation is then needed (Treadmill test, Doppler).
* Resting ABI is insensitive to mild PAD. Treadmill tests is then indicated to increase
ABI sensitivity, but this is unsuitable for patients who are obese or have comorbidities
such as Aortic aneurysm.
* ABI correlates poorly with result after revascularisation so it is not reliable method
alone of surveillance.
12. * The exact location of the stenosis or occlusion cannot be determined by ABI alone.
* Lack of complete protocol standardisation reduces intraobserver reliability.
* Skilled operators are required for consistent, accurate results. An incorrectly
performed test may lead to a false negative or a false positive result and thereby delay
the diagnosis or prompt unnecessary further testing.
* When performed in an accredited lab, the ABI is a fast, accurate, and painless exam,
however these issues have rendered ABI unpopular in primary care offices and
symptomatic patients are often referred to specialty clinics (13) due to the perceived
difficulties.
CONCLUSION
ABI It is a noninvasive, cost effective and reliable test used to detect lower extremity
peripheral arterial disease (PAD), to measure the severity of atherosclerosis in the legs
but is also an independent predictor of cardiovascular events and mortality. However,
alone this test is not appropriate to investigate PAD because of possibility of false-
negative findings and does not give enough directions for revascularisation in term of
localization and characterization.
Few contreIndications must be considered, especially in the setting of distal bypass.
Standardization of the technic is recommended as in AHA Scientific Statement (5).
Because of several limitations, Complementary tests are sometimes necessary to
detect PAD as Post Exercice ABI ( if borderline ABI values), Toe-Brachial Pression
Index (for incompressible arteries) and Doppler in inconclusive pressions Tests.
EXTERNAL LINK:
1- Stanford Medicine 25: Ankle Brachial Index
https://www.youtube.com/watch?v=KnJDrmfIXGw
2-Ankle--Brachial Index for Assessment of Peripheral Arterial Disease. SECEI ESCS.
https://www.youtube.com/watch?v=8q4Cz-a6zkQ
14. https://iame.com/online/physiologic_testing_for_assessment_of_peripheral_arterial_disease/
content.php
9- Wikipedia, the free encyclopedia, Anklebrachial Pressure index
10- Chan W Park et co, Ankle-Brachial Index Measurement.
http://emedicine.medscape.com/article/1839449-overview#showall
11- Matteo Montia, Lucia Mazzolaib et co. Mesure de l’«Ankle-brachial index» pour le dépistage
de l’artériopathie oblitérante des membres inférieurs.
Forum Med Suisse 2012;12(27–28):549–553
12- The ankle-brachial pressure index: An under-used tool in primary care?
Best Practice Journal 60, April 2014
http://www.bpac.org.nz/BPJ/2014/April/ankle-brachial.aspx
13- How to Perform a TBI Toe Brachial Index. Hokanson Online.
http://www.deh-inc.com/documents/How%20to%20Perform%20a%20TBI2.pdf
14- Treadmill Exercise Testing: UC Davis Vascular Center online.
http://www.ucdmc.ucdavis.edu/vascular/lab/exams/treadmill.html
15- Ma Circulation, en ligne.
http://www.macirculation.com/La-marche-sur-tapis-roulant_a51.html
16- Feringa HH, Bax JJ, van Waning VH, et al. (March 2006). "The longterm prognostic value of
the resting and postexercise anklebrachial index". Arch. Intern. Med. 166 (5): 529–35. doi:
10.1001/archinte.166.5.529.
PMID 16534039.
17- Wild SH, Byrne CD, Smith FB, Lee AJ, Fowkes FG (March 2006). "Low anklebrachial pressure
index predicts increased risk of cardiovascular disease independent of the metabolic
syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study".
Diabetes Care 29 (3): 637–42. doi:10.2337/diacare.29.03.06.dc051637
18- American Heart Association. Statistical Fact Sheet—Miscellaneous, 2008 Update. Peripheral
Arterial Disease— Statistics. http://www.heart.org/downloadable/heart/
1198011637413FS26PAD08.REVdoc.pdf.
15. 19- Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working
Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J
Vasc Surg. 2007;
45(suppl S):S5–S67.